RT Journal Article
SR Electronic
T1 The effect of non-genetic determinants of human milk oligosaccharide profiles in milk of Ugandan mothers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.21.24304661
DO 10.1101/2024.03.21.24304661
A1 Owalla, Tonny Jimmy
A1 Mwangi, Victor Irungu
A1 Moukarzel, Sara
A1 Okurut, Emmanuel
A1 Yonemitsu, Chloe
A1 Bode, Lars
A1 Egwang, Thomas G.
YR 2024
UL http://medrxiv.org/content/early/2024/03/22/2024.03.21.24304661.abstract
AB Background Human milk oligosaccharides (HMOs) protect against infection and promote growth and cognitive development in breastfeeding children. Non-genetic factors which influence HMO composition in breastfeeding mothers in rural Africa have not been investigated.Objective We undertook a cross-sectional study to determine the association between HMO profiles and non-genetic maternal factors and children’s sex in Ugandan mother-children pairs.Method Human milk was collected from 127 breastfeeding mothers by manual expression. HMO analysis was by high performance liquid chromatography. The proportion of each HMO per total HMO concentration was calculated. Spearman’s correlation and Mann-Whitney U test were used to assess the relationship between individual HMOs and maternal factors and infant sex.Result Nineteen HMOs were assayed. The prevalence of secretor and non-secretor status, based on the proportion of mothers with high milk concentrations of 2’FL and LNFP 1, was 80.3 % and 19.7 %, respectively. In secretor mothers, 2’FL, DFLac and LNFP I constituted > 57 % while in non-secretor mothers LNT and LNFPII constituted 46.9 % of the measured total HMOs. The median 3’SL concentration in milk of all mothers of male children was significantly higher than that in all mothers of female children. The median DFLac concentration in all mothers was significantly higher in multiparous mothers compared to primiparous mothers. Higher FDSLNH and lower LNH concentrations were observed in overweight secretor and non-secretor mothers, respectively. Median concentrations of LNFP I and DSLNT were significantly higher in all mothers < 18 years old compared all mothers > 18 years old. Concentrations of specific HMOs increased, decreased, or remained unchanged with increasing lactation duration in secretor and non-secretor mothers.Conclusions Specific HMOs were associated with infant sex and maternal age, parity and post-partum BMI in Ugandan mothers but were different from those reported in other populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThomas Egwang received funding from the Global Innovation Fund and Grand Challenges Canada. Lars Bode is UC San Diego Chair of Collaborative Human Milk Research endowed by the Family Larsson-Rosenquist Foundation (FLRF), Switzerland. The funders played no role in the study design, data collection and analysis nor in the preparation of the manuscript and decision to publish this paperAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Uganda National Council for Science and Technology and the Research Ethics Committee of the Vector Division, Ministry of Health, approved the original HD4MC study. All mothers who donated milk samples and brought infants to the malaria clinic signed or thumb-printed an informed consent form.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData described in the manuscript, code book, and analytic code will be made available upon request from TGE.2’FL2’fucosyllactose3 FL3-fucosyllatose3’SL3’sialyllactose6’SL6’sialyllactoseBMIbody mass indexDFLacdifucosyllactoseDFLNHDifucosyllacto-N-hexaoseDFLNTDifucosyllacto-N-tetroseDSLNHdisialyllacto-N-tetraoseDSLNTDisialyllacto-N-tetraoseFDSLNHFucosyldisialyllacto-N-hexaoseFLNHFucosyllacto-N-hexaoseFuc HMOHMO-bound fucoseFUT2α1,2-fucosyltransferase geneHMOshuman milk oligosaccharidesLNFPIlacto-N-fucopentaose ILNFPIIlacto-N-fucopentaose IILNFPIIIlacto-N-fucopentaose IIILNHLacto-N-hexaoseLNnTLacto-N-neotetraoseLNTLacto-N-tetraoseLSTbSialyllacto-N-tetraose bLSTcsialyllacto-N-tetraose cSia HMOHMO-bound sialic acid